Team siliconindia

• Aster DM Healthcare receives no objection from BSE and NSE for merger
• Merger aims to expand healthcare services across India
• Deal subject to shareholder and regulatory approvals

Aster DM Healthcare has received no objection letters from both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) for its planned merger with Quality Care India. This approval is a key step in combining the two healthcare companies to strengthen their presence in the Indian healthcare sector.

The merger, already approved by the boards of both companies, will merge Quality Care India into Aster DM Healthcare under the Companies Act. However, the plan still requires approvals from shareholders, creditors, and other regulators before it can be finalized.

Earlier, Aster DM Healthcare acquired a significant stake in Quality Care India through a share swap deal valued at Rs 849 crore. The merged company, to be named Aster DM Quality Care, will be jointly controlled by Aster’s promoters and BCP, the previous stakeholder in Quality Care India.

Also Read: Mahindra University & Apollo Launch New Health Science Courses

This merger will combine the strengths of both healthcare providers, aiming to expand access to quality medical care throughout the country. Aster DM Healthcare’s shares rose by 4.2% to close at Rs 672.30 on the BSE following the announcement.

By bringing together two leading players, the merged entity plans to enhance healthcare delivery and grow its footprint across India. The merger aligns with Aster’s vision to offer better medical services and innovate in the healthcare space.